Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Allianz    ALV   DE0008404005

ALLIANZ (ALV)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

European shares retreat after week of gains; Allianz rallies after update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 11:42am CEST
A plastic bull figurine, symbol of the Frankfurt stock exchange is pictured in front of the German share price index DAX board at the Frankfurt stock exchange

MILAN (Reuters) - European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

MILAN (Reuters) - European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

The pan-European STOXX 600 <.STOXX> index fell 0.5 percent but remained close to a 13-month high reached on Wednesday and on track to end higher for the second week in a row.

The rally has been fuelled by strong earnings updates, a pick up in merger and acquisition (M&A) activity, with cyclical stocks such as mining companies and banks lifted by solid economic data.

Allianz rose 2.4 percent. Europe's largest insurer proposed spending 3 billion euros on buying back its own shares after posting higher-than-expected profits and saying it was adjusting its policy on budgeting for possible takeovers.

The Munich-based firm also raised its dividend.

"The combination of a dividend increase and a share buy-back probably both at the upper end of market expectations is a sign of strength and should improve sentiment and provide tailwind for the shares," DZ Bank analyst Thorsten Wenzel said.

Elsewhere in the insurance sector, Dutch insurer Aegon (>> AEGON) rose as much as 4.2 percent as investors cheered to a stronger than expected pretax profit growth. Its shares pared gains and were last up 0.3 percent.

On the M&A front, Stada (>> STADA Arzneimittel AG) was once again in focus after the German generic drugs company said it had received its third takeover approach, valuing the company at 58 euros per share, above its current market value and higher than a previous takeover offer. Its shares rose 1.1 percent.

Some big drugmaker stocks were also in demand, lifting the healthcare index <.SXDP> up slightly and making it the only sectoral gainer in Europe.

Britain's AstraZeneca (>> AstraZeneca plc) and GlaxoSmithKline (>> GlaxoSmithKline plc) were up 1.6 percent and 0.5 percent respectively after analysts at Jefferies raised the price target for both.

Europe's STOXX bank index <.SX7P> fell 1.2 percent as investors booked profits for a second day after the index hit a three-week high on Wednesday, helped by growing expectations of a rate hike next month in the United States.

Deutsche Bank (>> Deutsche Bank AG), Standard Chartered (>> Standard Chartered PLC) and Credit Agricole (>> Crédit Agricole) fell between 2.6 and 2.8 percent.

Miners <.SXDP> were also weaker, down 1.1 percent, pulling back after climbing earlier this week to their highest level in more than two years. Copper slid on Friday because of some profit taking, but the likelihood of strong demand from top consumer China were expected to support prices.

"Short-term technicals remain in overbought territory making rounds of profit-taking...more likely," said Markus Huber, trader at City of London Markets.

Top loser on the STOXX was Vopak (>> Koninklijke Vopak), down 8.7 percent, after the Dutch oil and chemical storage company said it did not expect core profit to grow this year.

(Reporting by Danilo Masoni; Editing by Angus MacSwan)

By Danilo Masoni

Stocks mentioned in the article
ChangeLast1st jan.
AEGON 0.50% 6 Delayed Quote.12.89%
ASTRAZENECA 0.41% 4976 Delayed Quote.-2.83%
CRÉDIT AGRICOLE 0.63% 13.585 Real-time Quote.-1.56%
DEUTSCHE BANK -0.96% 11.574 Delayed Quote.-27.09%
GLAXOSMITHKLINE 1.61% 1430 Delayed Quote.8.13%
ROYAL VOPAK -0.35% 40.15 Delayed Quote.9.79%
STADA ARZNEIMITTEL 0.07% 84 Delayed Quote.-4.79%
STANDARD CHARTERED 2.56% 764.4 Delayed Quote.-2.01%
STOXX EUR 600(P)-EUR -0.03% 381.84 End-of-day quote.-1.88%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLIANZ
04/19ALLIANZ : Megacities and the Mobility Megachallenge
PU
04/18ALLIANZ : Battling passive funds, AllianzGI to launch UK performance fee option
RE
04/17ALLIANZ : Bid for unified car security standard on cellphone keys
AQ
04/17ALLIANZ : Bid for unified car security standard on cellphone keys
AQ
04/16Singapore's Temasek hikes Bayer stake in $3.7 billion share sale
RE
04/16ALLIANZ SE : Release of a capital market information
EQ
04/16JD.com takes $85 million stake in Allianz China unit
RE
04/13TENCENT : German mobile bank N26 to launch in Britain, U.S. in 2018, CEO says
RE
04/12STANDARD CHARTERED : EAIF mobilizes US$385 million to invest in Africa
AQ
04/12ALLIANZ : People, Planet, Prosperity
PU
More news
News from SeekingAlpha
04/11ROAD TO FINANCIAL INDEPENDENCE : My March 89-Stock Portfolio Review 
03/13ROAD TO FINANCIAL INDEPENDENCE : My February 88-Stock Portfolio Review With Big .. 
02/16Allianz SE ADR 2017 Q4 - Results - Earnings Call Slides 
02/16Allianz reports Q4 results 
02/14ROAD TO FINANCIAL INDEPENDENCE : My January 88-Stock Portfolio Review 
Financials (€)
Sales 2018 122 B
EBIT 2018 11 369 M
Net income 2018 7 555 M
Debt 2018 -
Yield 2018 4,48%
P/E ratio 2018 11,12
P/E ratio 2019 10,52
Capi. / Sales 2018 0,70x
Capi. / Sales 2019 0,68x
Capitalization 85 206 M
Chart ALLIANZ
Duration : Period :
Allianz Technical Analysis Chart | ALV | DE0008404005 | 4-Traders
Technical analysis trends ALLIANZ
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 213 €
Spread / Average Target 9,9%
EPS Revisions
Managers
NameTitle
Oliver Bäte Chief Executive Officer
Michael Diekmann Chairman-Supervisory Board
Christof Mascher Chief Operating Officer
Giulio Terzariol Chief Financial Officer
Rolf Zimmermann Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ALLIANZ1.07%104 687
CHUBB LTD-5.78%63 590
ZURICH INSURANCE GROUP5.46%49 242
AMERICAN INTERNATIONAL GROUP-6.97%49 148
MARSH & MCLENNAN COMPANIES1.86%42 652
HARTFORD FINANCIAL SERVICES GROUP (THE)-7.55%18 692